As my pump is nearing the end of it’s days and I’m on the look out for potential
Diatribe (who do a very nice monthly newsletter focussed around research and product developments in diabetes in case you’re interested) have been reporting back from the 4th International Conference on Advanced Technologies and Treatment for Diabetes (ATTD), which is the forum lots of big pharma choose to share their new products at.
Of particular interest (or not, but you can at least pretend to care) to ShootUp readers will be a tiny bit more info about the new Animas Vibe – Animas’ first step into the world of integrated pumps and CGM. I mentioned this briefly in my review of pumps on the market but details were non-existent. Diatribe have a paragraph on it, which is more than I managed so that’s progress, and some gentle poking of my local rep revealed they’re hoping to launch in the UK in April/May this year (although holding your breath for this is not advised).
And not to be left behind, Medtronic are also working on a new, improved CGM sensor which will come without the terror inspiring 3ft long insertion needle you need to use now (potential slight exaggeration here around the size of the needle, but when you first see it, it does make you quiver!).
A review of the conference overall shows the hot topics to be CGM and patch pumps (the tubeless variety of which Omnipod is the most well known) along with some interesting early stage work looking at using heat to increase the absorption speed of insulin – I suppose as an early stage trial I could take to wearing an extra jumper and see if that makes any difference?